About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Some (But Not All) Amendments Introduced in "Patent Reform" Bill | Main | Senate "Patent Reform" Bill (S. 515) Voted out of Judiciary Committee »

April 02, 2009

Comments

Rather than making reverse payment settlements illegal, it would be more effective to just revise the Hatch-Waxman Act to remove the incentive to enter into such settlements. Pharmaceutical patent holders generally enter pay-for-delay settlements with the first generic challenger because these settlements bottleneck the generic process by preventing FDA from approving later-filed ANDAs. The 180-day exclusivity forfeiture provisions allow the first-filer to hold on to his exclusivity even after entering a pay-for-delay settlement, so long as the settlement doesn’t stipulate anything about the patent being invalid or not infringed. A simple change to the Hatch-Waxman Act - having the first-filer forfeit their exclusivity period upon entering ANY settlement agreement with the patentee - would open the door to other generic challengers and disincentivize patentees from entering into such settlements in the first place.

The comments to this entry are closed.

November 2023

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30